 |
|
|
 |
U.S. drug prevention, treatment, enforcement agencies take on "doctor shoppers," "pill mills"
For the first time, the Bush Administration will carry out a coordinated drug strategy to confront the illegal diversion and abuse of prescription drugs. Today, President Bush's "Drug Czar," John Walters, joined FDA Commissioner Mark McClellan, DEA Administrator Karen Tandy, Surgeon General Dr. Richard Carmona, and Representative Tom Davis to release the President's National Drug Control Strategy, which outlines the extent of prescription drug abuse in the United States and new Federal programs designed to address the problem.
more
|
|
Fact sheet: Reducing prescription drug abuse
Non-medical use of addictive prescription drugs has been increasing throughout the United States at alarming rates. According to the National Survey on Drug Use and Health, in 2002, an estimated 6.2 million Americans reported past month use of prescription drugs for non-medical purposes. Nearly 14 percent of youth between the ages of 12 and 17 have used
such drugs, which include pain relievers, sedatives/tranquilizers, or stimulants, for non-medical purposes at some point in their lives. Emergency room visits associated with narcotic pain relievers have increased 163 percent since 1995.
more
|
|
U.S. administration document: The president's national drug control strategy (2004) (PDF 1.1MB)
In accordance with U.S. law, the president must present a drug control strategy during his or her administration. The document in today's Vidyya is the opinion and policy of the Bush administration. It is provided as a service to our readers. The size of the file is 1.1 MB and the file is in pdf format. For the first time, the Bush Administration will carry out a coordinated drug strategy to confront the illegal diversion and abuse of prescription drugs. On March 1, 2004, President Bush's “Drug Czar,” John Walters, joined FDA Commissioner Mark McClellan, DEA Administrator Karen Tandy, Surgeon General Dr. Richard Carmona, and Representative Tom Davis to release the President's National Drug Control Strategy, which outlines the extent of prescription drug abuse in the United States and new Federal programs designed to address the problem.
more
|
|
|
|
New imaging technique developed to identify breast cancer
Researchers at Johns Hopkins have for the first time used a chemical marker detected by proton magnetic resonance spectroscopic imaging (MRSI) to successfully diagnose breast cancer. The diagnostic technique produces pictures of choline within breast tumors. more
|
|
First avian genome now available to scientists worldwide
The National Human Genome Research Institute (NHGRI), one of the National Institutes of Health (NIH), today announced that the first draft of the chicken genome sequence has been deposited into free public databases for use by biomedical and agricultural researchers around the globe. more
|
|
NIH researchers discover promising new therapy for blinding eye disease
A preliminary clinical trial, conducted by researchers at the National Institutes of Health (NIH), found that an investigational treatment for uveitis (pronounced yoo-vee-eye-tis) seems to have many fewer side effects than existing therapies, leading to improved quality of life for patients with this potentially blinding disease. Accounting for an estimated 10-15 percent of blindness in the United States, uveitis is a condition in which tissues in the eye become inflamed.
more
|
|
Psychiatric study for cancer patients to measure psychoactive medication
Stage IV cancer patients who suffer from anxiety may want to investigate a new research study recently approved by the Food and Drug Administration (FDA) taking place at The Research and Education Institute at Harbor-UCLA Medical Center in Torrance, CA.
more
|
|
|
